Progress in tuberculosis vaccine development and host-directed therapies—a 
state of the art review

Kaufmann, Stefan H. E.; Lange, Christoph; Rao, Martin; Balaji, Kithiganahalli N; Lotze, Michael; Schito, Marco; Zumla, Alimuddin I; Maeurer, Markus

doi:10.1016/S2213-2600(14)70033-5

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review

MPS-Authors

/persons/resource/persons81969

Kaufmann, Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Kaufmann, S. H. E., Lange, C., Rao, M., Balaji, K. N., Lotze, M., Schito, M., et al. (2014). Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review. The Lancet Respiratory Medicine, 2(4), 301-320. doi:10.1016/S2213-2600(14)70033-5.

Cite as: https://hdl.handle.net/11858/00-001M-0000-001A-11DA-A

Abstract

There is no abstract available